Elanilam Pharmaceuticals, Inc. (ALNY) RNAi Roundtable: Exon 1 Targeting with Brazosiran for Huntington's Disease - Presentation (NASDAQ:ALNY) 2026-10-30.

Seeking Alpha Markets · 30 Oct, 23:30 UTC · Source

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.